Modified Luciferase Biosensors for cAMP Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current luciferase biosensors face limitations in sensitivity and specificity for detecting cAMP levels due to inherent properties of wild-type luciferases, such as altered activities and affinities upon phosphorylation or modification, which affect their bioluminescent signals and responses to cAMP changes.
Innovation Solution
Development of modified luciferases with heterologous, non-native cAMP binding sites and peptide linkers that enhance bioluminescence and responsiveness to cAMP, including circular permutations and insertions/deletions at specific residues, to create biosensors with improved luminescent signals and cAMP detection capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If wild-type luciferase is used as a biosensor, then the biosensor can detect cAMP changes, but the sensitivity and specificity are limited due to altered activities and affinities upon phosphorylation or modification
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of luciferase to alter its biochemical properties. Specific mutations are introduced to change the enzyme's affinity for cAMP and its resistance to phosphorylation, thereby improving measurement precision while maintaining signal stability. This involves changing the chemical parameters of the luciferase protein to optimize its biosensing characteristics.
2Measurement precision
If luciferase is modified to improve cAMP binding affinity, then biosensing accuracy improves, but the enzyme's native bioluminescent activity may be reduced
Solution Approach 1:
The patent applies local quality by making targeted amino acid substitutions at specific locations within the luciferase structure. Rather than globally modifying the enzyme, precise local changes are made to the cAMP binding region to enhance affinity, while carefully selecting mutations that do not disrupt the catalytic core responsible for bioluminescent activity. This localized modification strategy allows independent optimization of binding and catalytic functions.
3Adaptability or versatility
If phosphorylation sites are added to luciferase to enable cAMP-dependent regulation, then the biosensor responds to cAMP signaling, but the enzyme activity decreases significantly
Solution Approach 1:
The patent converts the harmful effect of phosphorylation-induced activity loss into a beneficial regulatory mechanism. By strategically placing phosphorylation sites in specific locations and using phosphomimetic mutations, the design transforms phosphorylation from a detrimental event into a controlled switch that enhances cAMP-responsive regulation while maintaining adequate baseline activity. The harm of activity decrease is converted into the benefit of improved signaling fidelity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified luciferases exhibit enhanced bioluminescent signals and responsiveness to cAMP, allowing for more accurate detection of cAMP levels and changes, thereby improving the sensitivity and specificity of cAMP biosensing applications.
Implementation Method 1
Luciferases are enzymes that catalyze the oxidation of a substrate (e.g., luciferin) with the concomitant release of photons of light
Data Source
AI summary
A modified luciferase protein which is a sensor for molecules including cAMP is provided. The modified luciferase protein includes one or more heterologous amino acid sequences, at least one of which directly or indirectly interacts with cAMP.